SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?


To: Sidney Merle Foster who wrote (298)3/16/1999 7:40:00 AM
From: Mason Barge  Read Replies (3) | Respond to of 422
 
There really isn't any explanation or anything to be done, it's the mystery of the market. Management has done an excellent job of increasing earnings, currently and for the future. There's really nothing else to do. It's a good outfit with solid growth.

I think the PE got a little high and it's just growing into its trousers, so to speak. Personally, I think that the earnings will be there in the next few quarters and the stock price will increase. And if it doesn't, and the PE keeps declining, eventually it'll start paying dividends!



To: Sidney Merle Foster who wrote (298)3/25/1999 7:00:00 AM
From: Thomas Kirwin  Respond to of 422
 
FDA Opinion/Feedback - Ready-ID.Com

One has to wonder if the FDA has given its seal of approval to Ready-ID.com? Perhaps the new and improved website incorporated their feedback.

While I doubt that full FDA approval is necessary to open the site I'd be willing to bet that Immucor solicited some sort of opinion so as to insure that there are no compliance issues.

Waiting for news!

Regards,

Tom